Skip to main content
SpringerLink
Log in

Dual benefits of ACE inhibitor therapy in heart failure

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Long-term treatment with an ACE inhibitor in patients with transient or ongoing heart failure has been shown to provide benefits in terms of both cardioprotection and cost reduction, according to the results of 2 studies presented at the 19th Congress of the European Society of Cardiology (ESC) [ Stockholm, Sweden; August 1997 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Gill Higgins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Higgins, G. Dual benefits of ACE inhibitor therapy in heart failure. Inpharma Wkly. 1105, 7 (1997). https://doi.org/10.2165/00128413-199711050-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199711050-00010

Keywords

Search

Navigation